Development of a Hyperactive Primary Hemostatic System During Off-Pump Lung Transplantation Resulting From an Unbalance Between von Willebrand Factor and Its Cleaving Protease ADAMTS13Hugenholtz, G. C. G., Ruitenbeek, K., Adelmeijer, J., Pereboom, I. T. A., Meijers, J. C. M., van der Bij, W., Porte, R. J., Erasmus, M. E. & Lisman, T., Jul-2015, In : American Journal of Transplantation. 15, 7, p. 1958-1966 9 p.
Research output: Contribution to journal › Article › Academic › peer-review
An unbalance between the platelet-adhesive protein von Willebrand factor (VWF) and its cleaving protease ADAMTS13 is a risk factor for thrombosis. Here, we assessed levels and functionality of VWF and ADAMTS13 in patients undergoing off-pump lung transplantation. We analyzed plasma of 10 patients and distinguished lung transplantation-specific effects from those generally accompanying open-chest surgeries by comparing results with 11 patients undergoing off-pump coronary bypass graft (CABG) surgery. Forty healthy volunteers were included for reference values. VWF antigen levels as well as the VWF ristocetin cofactor activity/VWF antigen ratio increased during lung transplantation and after CABG surgery. An increase in VWF propeptide levels was paralleled by a decrease in ADAMTS13 activity. This was more pronounced during lung transplantation. Similarly, the capacity of plasma to support platelet aggregation under shear flow conditions in vitro was more increased during lung transplantation. The proportion of high molecular weight VWF multimers was elevated in both groups without evidence for ultra-large VWF. VWF's collagen binding activity remained unchanged. In conclusion, a hyperactive primary hemostatic system develops during lung transplantation resulting both from a pronounced (functional) increase of the VWF molecule and decrease of ADAMTS13. This may increase the risk of platelet thrombosis within the allograft.
|Number of pages||9|
|Journal||American Journal of Transplantation|
|Publication status||Published - Jul-2015|
- DONOR LIVER-TRANSPLANTATION, PRIMARY GRAFT FAILURE, PLATELET-ADHESION, P-SELECTIN, PLASMIN, DEFICIENCY, ACTIVATION, BYPASS